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a  b  s  t  r  a  c  t
Over  the past  decade  numerous  publications  have  demonstrated  how  digital  PCR  (dPCR)  enables  precise
and sensitive  quantiﬁcation  of nucleic  acids in a  wide  range  of applications  in both  healthcare  and  envi-
ronmental  analysis.  This  has  occurred  in parallel  with  the  advances  in  partitioning  ﬂuidics  that  enable  a
reaction  to be  subdivided  into  an increasing  number  of partitions.  As the  majority  of  dPCR  systems  are
based  on  detection  in  two  discrete  optical  channels,  most  research  to date  has  focused  on quantiﬁcationeywords:
PCR
igital PCR
uplex
igher order multiplexing
ultiplexing
of  one  or  two  targets  within a single  reaction.  Here  we describe  ‘higher  order  multiplexing’  that  is  the
unique  ability  of dPCR  to  precisely  measure  more  than  two  targets  in the same  reaction.  Using  examples,
we  describe  the  different  types  of  duplex  and multiplex  reactions  that can  be achieved.  We  also  describe
essential  experimental  considerations  to ensure  accurate  quantiﬁcation  of  multiple  targets.
© 2016  The  Author(s).  Published  by Elsevier  GmbH.  This  is  an  open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).ontents
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. Introduction
Digital PCR (dPCR) involves the partitioning of a PCR reac-
ion into a number of smaller partitions so that a proportion of
hem contain no template molecules [1,2]. PCR is then performed
o determine the proportion of positive (with ampliﬁcation) and
egative (no ampliﬁcation) partitions. This subdivision enables
uantiﬁcation to be performed using established statistical mod-
ls that are independent of a calibration curve [3] and increases
he precision of the quantiﬁcation [4–8]. There are two  broad
echanisms for the subdivision of a reaction: partitioning using
anoﬂuidics to load the reaction into prefabricated chambers, or
y generation of water-in-oil emulsions. The partition volume can
ary from 4.4 L down to 5 pL and the partition number in a reac-
ion can vary from 496 up to 10 million partitions depending on the
PCR platform used [9].
dPCR has been used in a wide range of research areas that include
easurement of copy number variation in genetically modiﬁed
rganisms [10,11] and for karyotyping plants [12,13] as well as in
uman disease models such as gene expression [14] and epigenetic
ontrol of gene expression in cancer [8,15,16], gene ampliﬁcation
n cancer [6,17] and prenatal fetal karyotyping [18]. The other
ajor application for dPCR is in the detection of rare sequence vari-
nts, which in standard qPCR can be lost within the high abundant
ackground type [17,19]. Such measurements have been evaluated
n many human diagnostic areas that include cancer stratiﬁca-
ion [20,21], antimicrobial resistance monitoring [22,23], prenatal
iagnostics [24,25] and monitoring of transplant organ rejection
26]. Most recently, dPCR is ﬁnding multiple applications in the
merging ﬁeld of liquid biopsy, where solid tumors are proﬁled
on-invasively based on detection of tumor-related nucleic acids
n blood or other anatomical liquids [27–29].
.1. Detection of ampliﬁcation
dPCR relies on the ability to distinguish between partitions that
ontain amplicons and those that do not. Partitions that contain
mplicons can be identiﬁed by the presence of increased ﬂuores-
ence using a variety of detection chemistries common to qPCR
uch as intercalating DNA dyes or ﬂuorophore-labelled oligonu-
leotides [30]. Following PCR cycling, the ﬂuorescence end-point
ignal associated with each partition is measured by the reader
nstrument. This signal can be plotted on a one-dimensional (1D)
catter graph, with the event (partition) number along the x-axis
nd the ﬂuorescent amplitude along the y-axis. In a well optimized
ssay, two visually distinct populations are observed; positive par-
itions that have high ﬂuorescence, and negative partitions that
ave low (or background) ﬂuorescence. An automatic threshold is
et by the software to separate these two populations, however,
or all the dPCR platforms it is possible for the user to manually set
he threshold in the analysis software and this is described in more
etail in Section 4.4.
.2. Basics of quantiﬁcation
Experimentally, we can only distinguish between negative par-
itions (containing zero targets) and positive partitions (containing
ne or more targets). The fundamental assumption of independent
istribution of target molecules into equal volume partitions means
hat the number of targets per partition will follow a standard Pois-
on distribution. The Poisson model is deﬁned by a single parameter
’—the average number of targets per partition. Historically,  is
epresented as:
 = − ln
(
1 − k
n
)
(1)nd Quantiﬁcation 10 (2016) 15–23
where n is the total number of partitions detected and k is the
number of positive partitions detected as deﬁned in the “Minimum
Information for Publication of Quantitative Digital PCR Experi-
ments” (dMIQE) guidelines (3). Eq. (1) is written in this way to
use the positive partitions (k) as a proportion of total partitions
(n). These were chosen as working with positive partitions is more
intuitive to the user. However,  is really calculated using the neg-
ative partitions as the proportion of positive partitions in Eq. (1),
k/n is subtracted from 1.
The negative partitions are arguably more informative than the
positive partitions since we  know each negative partition contains
zero copies of the target, while a positive partition may  contain one
or more copies of the target. When multiplexing,  needs to be cal-
culated for each targets individually and the notion of a positive
partition becomes dependent on the target of interest. In a sense
a ‘positive’ partition becomes even less informative as it may con-
tain 1 or more copies of multiple targets. If w denotes the number
of partitions that are negative for a target and so n = k + w.  By sub-
stituting w into Eq. (1) we can calculate  in terms of the number
of negative partitions,  = −ln (w/n), that can then be rearranged to
give Eq. (2):
 = ln (n) − ln (w) (2)
This arrangement allows for easier generalization in the case of
multiple targets. The full advantage of Eq. (2) is realised when we
want to quantify a target in a sample without using all the parti-
tions in that reaction. Speciﬁc scenarios and examples where this
is useful are given below in the relevant sections along with the
appropriate generalization of Eq. (2).
For any given experiment, both Eqs. (1) and (2) provide an esti-
mate of  and the uncertainty of  can be calculated using equations
that are described elsewhere [6,31]. In certain cases the assumption
of independent target distribution may  not hold, for example, with
close tandem copies [6] or denatured DNA [32,33]. Furthermore,
molecular dropout may  occur, where a molecule fails to amplify
and so a partition that initially contained a molecule is wrongly
classiﬁed as negative [34]. In such cases the estimate of  will not
be accurate as the binomial distribution is no longer appropriate.
2. Duplex assays
Duplex assays enable concurrent ampliﬁcation of two  targets
within a single reaction. This reduces technical errors, such as
accumulated pipetting inaccuracy, thereby making it possible to
measure smaller differences than the same comparison using par-
allel uniplex reactions [34]. Duplexing also reduces reagent and
time needs. Duplex assays can be performed with intercalating DNA
dyes or ﬂuorophore-labelled oligonucleotides; the examples illus-
trated in this study use hydrolysis probes, but the theory holds
true for other ﬂuorophore-labelling strategies such as Scorpion
or AmpliﬂuorTM primer-probes or hybridisation probes such as
Molecular Beacons [30].
In duplex hydrolysis probe assays, the two probes are typically
labelled with a different dye to match the two  detection channels.
There are four possible conﬁgurations in terms of the number of
primer pairs used in the reaction (1 or 2) and if the two  probes bind
the same region of the generated amplicon(s) (Table 1). Only three
conﬁgurations are meaningful, since the fourth one is unlikely to
occur where different primers generate amplicons containing the
same probe binding site.An alternative strategy for duplex reactions is to use a single-
colour intercalating DNA dye, such as EvaGreen, to amplify
amplicons of different sizes for the different targets; the targets
are discriminated by the differences in the ﬂuorescence ampli-
A.S. Whale et al. / Biomolecular Detection and Quantiﬁcation 10 (2016) 15–23 17
Table  1
Possible reaction conﬁgurations for duplex reactions.
Number of primer pairs
1 2
Probes binding same region Competing duplex reaction; e.g. rare mutant
detection (Fig. 1B)
N/A
different region Non-competing (hybrid) duplex reaction
(Fig. 1C)
Non-competing duplex reaction; e.g. copy
number variation (Fig. 1A)
Fig. 1. Graphical outputs for duplexing strategies. All illustrative examples given here used the QX200TM Droplet DigitalTM PCR System (Bio-Rad). A schematic is given for
the  primer and probe hybridisation arrangements with an example of the conﬁguration of clusters in the 2D plot underneath. For each plot, the amplitude in channel 1
(ch1)  is represented on the y-axis with the amplitude in channel 2 (ch2) represented on the x-axis. Four clusters are identiﬁed as single-positive for Ch1 (blue) and Ch2
(green), double-positive (orange) and double-negative (grey). (A) For non-competing duplex reactions, a rectangular conformation is observed between the four clusters. The
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hybrid) duplex reactions, only three clusters are visible. Discrimination of the varia
ude associated with amplicon size [35]. This is often referred to
s ‘amplicon-size multiplexing’.
.1. Non-competing duplex reactions (two primer pairs)
A standard duplex reaction generates two amplicons from two
rimer sets with the signal generated from a probe speciﬁc for each
mplicon. Fig. 1A illustrates two targets, A and B, that are being
uantiﬁed. A two-dimensional (2D) scatter graph can be generated,
here the ﬂuorescent amplitude of one probe channel (ch1), that
epresents target A, is plotted on the y-axis and the other probe
hannel (ch2), that represents target B, is plotted on the x-axis. In
his graph a partition can fall into one of four possible clusters:
i) negative partitions that contain no ampliﬁed targets, positive
artitions for (ii) target A or (iii) target B (collectively referred to as
ingle-positive partitions), and (iv) positive partitions that contain
 positive signal for both targets (double-positive partitions).
Typically, the four clusters are arranged in a rectangular con-
guration with the double-positive cluster having approximately
he same amplitude in both channels as the single-positive clus-
ers (Fig. 1A). In some cases the double-positive cluster may  exhibit
ower amplitude for one of the targets; this occurs when one ampli-
on is preferentially ampliﬁed at the expense of the other. Causes
f this imbalance can include primer characteristics such as differ-
nces in melting temperature, secondary structure, or the primers
egatively interfering with each other [36].
As long as thresholds can be set to separate the positive and
egative partitions in each of the two probe channels then the
stimation of the concentration of both targets using either Eqs.
1) or (2) will still be suitable. The typical result produced with
uch assay conﬁgurations is the ratio of the concentrations of the
wo targets. Examples of this type of reaction have been used in-positive clusters. (B) For competing duplex reactions, the four clusters have been
s dropped inwards and formed an arc across the scatter plot. (C) For non-competing
d double-positive clusters is not possible (all partitions are coloured orange).
the identiﬁcation of HER2 ampliﬁcation in breast cancer patients
[37–39].
2.2. Competing duplex reactions (one primer pair with two
probes binding the same region)
An alternative duplex format ampliﬁes two  amplicons using a
single pair of primers. The identity of the two amplicons is speciﬁed
by the signal from the bound probe; one probe for each amplicon.
This is a typical conﬁguration for quantiﬁcation of localised vari-
ants that include single nucleotide polymorphisms (SNP), single
nucleotide variants (SNV) and small insertions or deletions. The
speciﬁcity of the variant detection is conferred by one of the two
probes; one for the abundant or wild type (WT) sequence and one
for the variant. Examples of this type of reaction have been used in
the identiﬁcation of the EGFR mutations in cell free DNA extracted
from plasma in lung cancer patients [27,40] and BRAF mutations in
melanoma [41,42].
Similar to the non-competing duplex reaction, four clusters of
partitions are generated. However, unlike non-competing duplex
reactions, the double-positive cluster forms an arc conformation
that spans the two single-positive clusters (Fig. 1B). This is primar-
ily caused by a phenomenon caused partition speciﬁc competition
(PSC) described in more detail in Section 4.3. Quantiﬁcation can
be harder as the competitive nature of the reaction in the double-
positive partitions can make it difﬁcult to position the thresholds
for each probe channel. However, once thresholds are set to sepa-
rate the four clusters, quantiﬁcation of each target can be performed
as described above. The typical result produced with such assay
conﬁgurations is the fractional abundance of the variant target
relative to the sum of abundant and variant targets. Alternative
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.3. Non-competing (hybrid) duplex reactions
The third conﬁguration of duplex reactions using probes
ncludes the ampliﬁcation of a single amplicon with two
on-competing probes; these are often referred to as “Wild-Type-
egative” or “drop-off” assays. The universal (or reference) probe
argets an area of the amplicon that is not expected to be variable
nd thus, provides a reference for the total number of molecules
resent in the sample irrespective of sequence. The variant probe
argets the area of the amplicon that is expected to contain one or
ore variants. A typical use for this type of assay is in detection of
 broader set of possible mutations than can be covered by a single
robe, for example, exon 19 deletions in the EGFR gene [27].
In this conﬁguration, there are only three visible clusters
Fig. 1C): (i) negative partitions that contain no targets for either
robe, (ii) single-positive partitions for the universal probe (WT
nly partitions) and (iii) positive partitions that contain a sig-
al from both variant and universal probes (combined cluster).
he missing single-positive cluster (variant only partitions) is sub-
umed into the combined cluster since the universal probe always
roduces a signal in the presence of any amplicon. For quantiﬁca-
ion of the targets we will use Eq. (2) and deﬁne c0 as the number
f partitions in the double-negative cluster, cwt for the WT  only
luster and ccombined for the combined cluster:
variant = ln (c0 + cwt + ccombined) − ln (c0 + cwt) (3)
wt = ln (c0 + cwt) − ln (c0) (4)
Here we have extended Eq. (2) to use the relevant number of
artitions for the different targets. Eq. (3) uses all partitions, while
q. (4) uses a subset of all partitions. These equations also assume
here are no interactions between the targets so that the a priori
inomial distributions of positive and negative partitions for each
arget are independent of each other. Since, the overall precision
f dPCR measurements depends on the number of partitions used
43,44], the precision of wt is lower than the precision of variant .
owever, the quantiﬁcation trueness of both targets is the same in
hat they are both unbiased.
.4. Duplexing using non-speciﬁc double stranded DNA binding
yes
Multiple targets can be quantiﬁed using a single double stranded
NA binding ﬂuorescence dye, such as EvaGreen. This method
xploits the relationship between the proportionate level of end-
oint ﬂuorescence and amplicon size. An alternative strategy
nvolves varying the primer concentration for the two  different
ssays, whilst keeping the amplicons at comparable lengths. These
ypes of reaction can be used to calculate the ratio of the concen-
rations between the two targets. Examples of this type of reaction
ave been used in the quantiﬁcation of RPP30 and ACTB (amplicon
ultiplexing) and CNV identiﬁcation of MRGPRX1 in HapMap sam-
les (primer multiplexing) [35] and the V600E point mutation in
he BRAF gene [45]. When all canonical clusters of partitions can be
esolved, quantiﬁcation is done the standard way. In some cases,
ike in non-competing hybrid probe assays, one of the single pos-
tive clusters may  be subsumed into the double positives. We  can
hen apply the same strategy for full target quantiﬁcation.. Higher order multiplexing
In traditional qPCR multiplexing reactions, targets are differen-
iated using one probe per target conjugated with dyes of differentnd Quantiﬁcation 10 (2016) 15–23
emission spectra. This approach restricts multiplexing to systems
that can cope with multiple emission spectra to capture the ﬂuo-
rescence from the different probe dyes. There are currently two
commercial systems, the Fluidigm BioMarkTM and EP1TM sys-
tems and the recently commercialised Stilla NarciaTM System, that
have the capacity to multiplex in four and three optical channels,
respectively. The other commercially available dPCR systems are
restricted to detection in two  discrete optical channels. Despite
this, it is possible to precisely measure more than two targets in
the same reaction [46]. This is termed ‘higher order multiplexing’
and is a unique property of dPCR.
The fundamental idea behind higher order multiplexing is that
the end-point ﬂuorescence amplitude in each partition is a function
of probe-dye conjugation and mixing, probe and primer concentra-
tions and the type of targets that are present prior to ampliﬁcation.
Each partition is still detected individually and will be repre-
sented as an event in a 2D scatter plot. By understanding and
deconvoluting the resulting patterns, multiple targets can be quan-
tiﬁed simultaneously. When each partition can be unambiguously
assigned to a cluster, the full statistical power can be used to achieve
maximal precision and accuracy.
In some cases different clusters may  overlap in 2D space and,
as we  observed with the non-competing duplex reactions (Section
2.3), it is still possible to quantify speciﬁcally, albeit at the expense
of reduced precision. We  will ﬁrst cover the cases with full cluster
discrimination (amplitude- or ratio-based multiplexing) and then
describe the use of multiplex reactions that quantify the targets
using only a subset of all partitions.
3.1. Amplitude-based multiplexing
In an amplitude-based multiplex assay, targets are detected
with probes conjugated with a single dye but at a different ﬁnal con-
centration in the end-point reaction. This approach is similar to the
non-speciﬁc double stranded DNA binding dye approach (Section
2.4). This strategy can be modiﬁed to measure three or more tar-
gets per reaction. In our illustrated example, four targets are being
quantiﬁed in a ‘tetraplex’ reaction (Fig. 2A). Targets A and B have
relative concentrations of 50% and 100% of Ch2-labelled probes,
respectively; while C and D have relative concentrations of 50% and
100% of Ch1-labelled probes, respectively, giving 16 (24) possible
clusters in the 2D amplitude space.
For this set up, single, double, triple and quadruple-positive clus-
ters arise as a partition can contain any combination of the target
types. For most precise quantiﬁcation, all 16 clusters need to be
uniquely identiﬁed and the number of partitions in each cluster to
be reliably counted (Fig. 2A). Deﬁning the threshold positions for
this set up is more complicated than those for duplex reactions. In
the example shown, all 16 clusters can be identiﬁed and so estimate
the concentration of each target can be achieved using either Eqs.
(1) or (2). For example, the lasso tool can be used to select all the
clusters that do not contain target B (wB) (Fig. 2B) and using Eq. (2),
the concentration of target B can be computed:
 = ln (n) − ln (wB) (5)
A typical application for such multiplex assays could be for more
accurate estimation of the copy number of a target such as the eval-
uation of DNA integrity extracted from parafﬁn embedded tissue
[47].
3.2. Ratio-based multiplexing with complete cluster identiﬁcationIn ratio-based multiplexing assays some targets are detected in
the conventional way, while others are detected using two  probes
conjugated with different dyes. In the illustrated example three
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Fig. 2. Graphical outputs for higher order multiplexing strategies. All illustrative examples given here used the QX200TM Droplet DigitalTM PCR System (Bio-Rad). For each
multiplexing strategy a schematic and worked example of the conﬁguration of clusters in the 2D plot is given with the amplitude in channel 1 (ch1) is represented on the
y-axis  with the amplitude in channel 2 (ch2) is represented on the x-axis. For each schematic the approximate location of the single target positive clusters are identiﬁed as
solid  coloured circles with the double or triple target positive clusters are shown as dotted circles. For the worked examples, the clusters are not pseudocoloured according to
the  target due to the limitations of the software. (A) For amplitude-based multiplexing, four independent targets are being quantiﬁed: targets A (100% Ch2-labelled probe),
B  (100% Ch2), C (50% Ch1) and D (100% Ch1) giving 16 possible clusters in the 2D amplitude space. For the worked example, all the clusters containing partitions that do not
contain  target B are lassoed (wB). (B) For ratio-based multiplexing, three independent targets are being quantiﬁed: targets A (100% Ch2), B (100% Ch1) and C (50% Ch2 and 50%
Ch1)  giving 8 possible clusters in the 2D amplitude space. For the worked example, the four clusters used in the quantiﬁcation are lassoed and labelled: negative cluster for all
targets (c0), single-positive for target B (cB), single-positive for target A (cA), and double-positive for targets A and B (cAB). (C) For ratio-based non-discriminating multiplexing,
ﬁve  targets are being quantiﬁed: targets A (100% Ch2), B (75% Ch2/25%Ch1), C (50% Ch2/50% Ch1), D (25% Ch2/75% Ch1) and E (100% Ch1). A total of 32 combinations of
clusters  are possible, however, due to the ratios of the probes for the different targets, most are not uniquely identiﬁable. For example, a cluster containing both targets A and
D  (125% Ch2/75% Ch1) would not be distinguishable from a cluster containing both targets B and C (also 125% Ch2/75% Ch1). Therefore only the single-positive clusters can be
used  in the quantiﬁcation. For the worked example, the two clusters used for the quantiﬁcation of target D are lassoed: negative cluster for all targets (c0) and single-positive
cluster for target D (c ). (D) For non-discriminating multiplexing the example of the KRAS mutations in codons 12 and 13 is shown. The 7 probes for the mutant SNVs are
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ll  conjugated with the Ch1-labelled probe and the WT probe is conjugated with
ith  a single cluster in the WT channel. The double-positive cluster is also visible. I
uantiﬁcation of the total number of mutant sequences only.
argets are being quantiﬁed (Fig. 2B). Targets A and B have rela-
ive concentrations of 100% Ch2- and 100% Ch1-labelled probes,
espectively. Target C has relative concentrations of 50% Ch2- and
0% Ch1-labelled probes. The expected location of the target C
ingle-positive cluster is in between those of targets A and B, where
oth probe channels have a 50% reduction in ﬂuorescent amplitude.
ncluding the double- and triple-positive clusters gives a total of 8
23) identiﬁable clusters for all possible combinations of the three
argets.
In this example, we can use either Eqs. (1) or (2) to quantify the
umber of target molecules as described in the previous section.
owever, the full advantage of using Eq. (2) over Eq. (1) can be
llustrated when we want to quantify based on a subset of clusters.
or example, we might want to exclude all clusters that contain
arget C from the quantiﬁcation and so use only the clusters that
o not contain target C (Fig. 2B). Therefore, the total number of
he partitions in the reaction and the number of partitions that are
egative for target B are deﬁned as:
notC = c0 + cA + cB + cAB (6)
B = c0 + cA (7)
From this we can then use Eq. (2) to estimate the concentration
f target B:
B = ln (c0 + cA + cB + cAB) − ln (c0 + cA) (8)
Whether we use all partitions or a subset of partitions, we will
chieve unbiased estimates, as long as there is no linkage between
he targets (see Section 4.1). We  may  need to use fewer clusters if
ome clusters are not uniquely identiﬁable, poorly deﬁned or not
ll accounted for in the reaction (a sample may  not contain targeth2-labelled probe. Three diffuse clusters are visible in the mutant probe channel
t possible to discriminate between the 3 mutant clusters and so this set up allows
C). Again, this method enables us to preserve the accuracy while
giving some ground on precision.
3.3. Ratio-based multiplexing with incomplete cluster
identiﬁcation
In some cases, a careful selection of the ratios of the probes
would allow an operator to multiplex even more targets in a single
reaction. This may  require use of an incomplete set of clusters. In
the illustrated example ﬁve targets are quantiﬁed (Fig. 2C). Targets
A and E have relative concentrations of 100% Ch2 and Ch1-labelled
probes, respectively. Targets B, C and D have labelled Ch1 and Ch2-
labelled probes at varying ratios. In this setup we  should see a total
of 32 (25) different combinations of the ﬁve targets; however, many
of these clusters may  not be uniquely identiﬁable. For example, the
position of the double-positive partitions containing targets A and
D may  overlap with that of the double-partitions containing targets
B and C (Fig. 2C). In many cases higher order positives also cannot be
uniquely identiﬁed. Nevertheless, one can achieve accurate quan-
tiﬁcation by using only the single-positive clusters. For example, to
calculate the concentration of target D using Eq. (2) we only need
to count the number of partitions in the negative cluster (c0) and
the single-positive cluster that contains target D (c ) (Fig. 2C):This method allows for interrogation of multiple targets at the
expense of reduced precision. As before the estimates for average
occupancies for each target are unbiased.
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Fig. 3. Considerations for accurate quantiﬁcation. All illustrative examples given here used the QX200TM Droplet DigitalTM PCR System (Bio-Rad) using duplex reactions;
however, all of these are relevant for higher order multiplexing strategies. (A) For the analysis of a probe-competing duplex reactions to quantify a transition mutation.
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Cross-hybridisation of the probes caused by either mismatched binding of the pro
ingle-positive clusters. This can impact on positioning the thresholds to separate 
cid  deletion mutation to illustrate that mismatched binding of the probes does no
.4. Non-discriminating multiplexing
To complete our survey of multiplexing assays we  next describe
he case where some targets are detected but will never be uniquely
dentiﬁed as this is not required by the application. In such exper-
ments, we wish to report the presence and quantity of any
ombination of the targets of interest. A typical example is pre-
ented in Fig. 2D where all 7 mutations in the KRAS gene, exons
2 and 13, are Ch1-labelled probes, while WT  has a Ch2-labelled
robe. The 7 mutant species generate 3 diffuse mutant clusters but
e combine the counts of those for the purposes of quantiﬁcation.
Identiﬁcation of the speciﬁc mutation is not required as the fun-
amental question is ‘does this sample contain mutations’ and so
he reaction performs a screening role. Such screening assays are
seful when the expected prevalence of mutations is low and it is
ore efﬁcient to only determine the speciﬁc mutation in the sam-
le once the presence of a mutation has been conﬁrmed. Multiplex
creening in this style typically leads to reduced sensitivity limits
han when detecting individual targets. For quantiﬁcation we can
se Eq. (2) as described for competing duplex reactions (Section
.2).
. Considerations for accurate quantiﬁcation
Several factors are important for accurate quantiﬁcation of mul-
iplexed assays. These include target linkage, probe speciﬁcity and
ompetition, differential PCR efﬁciencies. Any factor that distorts
he location and uniqueness of clusters needs to be taken into con-
ideration, especially when multiple targets are measured. Due to
he extra level of complexity in these types of reactions, care should
e taken to recognise and reduce these effects by rigorous optimisa-
ion to ensure accurate estimation of . In this section we describe
n more detail the causes of these factors and the effects they can
ave on the quantiﬁcation if they are not recognised and accounted
or.
.1. Linked targets
Quantiﬁcation of linked targets by dPCR may  cause problems
s the assumptions for random and independent (Poisson) distri-
ution of target molecules may  not hold. Tandem repeat copies of
he same target would co-localize in the same partition more fre-
uently than by chance, which will lead to an underestimation of
he true number of copies. In the case of two different targets in cis
nd nearby, there will be an excess of double positive partitions.
e can measure the concentration of each target using standard
pproaches but may  miss the fact the targets are indeed linked [48].
urrent standard analysis tools can report the concentration of the ﬁlter bleed-though can be visualised as a ‘leaning’ (blue) or ‘lifting’ (green) of the
ur clusters. (B) Analysis of a probe-competing duplex reaction to detect a 3 amino
e the ‘leaning’ or ‘lifting’ of the clusters compared with that observed in (A).
linked molecules using linkage-based assays to measure cis versus
trans conﬁguration of targets and potential structural rearrange-
ments [49]. This can be further extended to determine the degree
of DNA fragmentation under different extraction conditions. Care
needs to be taken when using a reduced set of clusters for quantiﬁ-
cation as this approach is in general valid under the assumption of
no linkage or higher order target correlations.
4.2. Speciﬁcity
The design of an assay for detection of SNVs is naturally some-
what constrained. In an ideal scenario, the two probes will have
stringent enough speciﬁcity, such that only ‘fully matched hybridi-
sation’ will occur; the WT  probe will hybridise to the amplicons
containing the WT  sequence only and the variant probe will
hybridise to the amplicons containing the mutant sequence only.
However, for many SNV assays, cross-(mismatched) hybridisation
of the probes does occur. As mismatches occur with lower efﬁciency
than matches, this will lead to ‘leaning’ or ‘lifting’ of the single-
positive partitions in the 2D scatter plot (Fig. 3A). For comparison,
cross-hybridisation is less pronounced when the probe targets a
variation involving two or more nucleotide deletions or insertions
(Fig. 3B).
This loss of speciﬁcity can be further compounded by optical
bleed-through, where the ﬂuorescence from a dye is picked up by
both detection channels (often referred to as ‘ﬁlter cross-talk’). This
effect produces a similar ‘lifting’ of the clusters and may  be hard
to separate from probe cross-hybridization effects. Filter cross talk
can be alleviated by careful selection of conjugated dyes that match
optical detection systems and by adjustment of signal processing
parameters in the analysis software where this is possible.
4.3. Effects of partition speciﬁc competition (PSC)
In dPCR any partition is a miniature reaction by itself. As such,
competition effects during PCR may  be present. The degree to which
those matter will depend on factors such as which targets and
how many molecules of each target are present in each partition,
differential ampliﬁcation efﬁciencies, DNA accessibility and tem-
plate quality. Every partition will follow standard ampliﬁcation
trajectory with an early exponential ampliﬁcation followed by a
saturation phase.
For CNV-like duplex assays (Section 2.1), there is no direct probe
competition. However, in the double-positive partitions (where
both targets are present at start) there will be two PCR reactions
competing for resources. In the case where efﬁciencies are roughly
balanced, the amplitudes of the double-positive partitions will be
similar to the amplitudes of single-positive partitions. An imbal-
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Table  2
Experimental setup to assess an assay in duplex (with WT or variant templates).
Approximate template  Reaction format Purpose
Variant WT/other
0.7 – Duplex Evaluate SNV speciﬁcity (probe cross-hybridisation & ﬁlter bleed-through)
–  0.7 Duplex
0.7 – Uniplex Evaluate ﬁlter bleed-through
0.7 Uniplex
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<0.05 – Duplex 
<0.025 <0.025 Duplex 
nce of efﬁciencies may  result in one amplicon outcompeting the
ther which will manifest as a ‘drop’ in amplitude in one probe
hannel relative to the canonical rectangular conﬁguration.
In the case of SNV-like assays (Section 2.2), the competition is
onstrained to the probes only. A curious phenomenon occurs for
ome assays to give an arc-shaped cluster that exhibits a clear sub-
luster structure (Fig. 1B). The source of the sub-clusters in this
ase is the different initial conditions for double-positive partitions;
ome may  start with one molecule of each WT  and variant, while
ome may  have ratios of the two molecules such as 2:1, 1:2, 3:1
nd so on. When the assay has very speciﬁc probes for each target
hese different initial conditions will be still detectable in the ﬁnal
nd-point picture.
.4. Other factors that can effect quantiﬁcation
While a dPCR reaction generates positive and negative parti-
ions, in many cases, a subset of partitions will be detected that have
 signal that is higher than the negative but lower than the posi-
ive partitions. These partitions are often referred to as ‘rain’. There
re a number of factors that affect the amount of rain observed
nd these include, but are not limited to template type (e.g. plas-
id, genomic DNA or cDNA), template conformation (e.g. linear or
upercoiled), template integrity (e.g. high molecular weight or frag-
ented), assay speciﬁcity, reduced PCR efﬁciency or the presence
f inhibitors in the reaction [3,34,50,51].
In these situations, the user can either use the threshold position
s set by the in-built software algorithms for the speciﬁc dPCR plat-
orms, or they can manually set the threshold, the latter of which
an be subjective. In order to reduce the subjective nature of the
ser setting and to try and standardise the data analysis method,
hree recent publications have described methods to aid operators
o set the thresholds appropriately. One describes a JavaScript code
deﬁnetherain’ where the threshold is determined by the k-nearest
eighbour algorithm of a control sample [52]. The second method
ses a manual global threshold (MTg) approach that is based on
he amplitude signal observed in negative control samples [53].
he third method describes a procedure based on kernel density
stimation using the end-point ﬂuorescent readings from each par-
ition [54]. In general, well designed assays will provide enough
white space’ between the positives and negatives, so presence of
rain’ is a clear indication of sample-related problems. Whether to
nclude the rain partitions into the positive or negative populations
epends on the desired performance. In some cases, where many
arget copies are present, rain partitions make up a small fraction
f the total partition number. In cases where detection of true rare
ariant molecules is critical, it may  be advisable to bias thresh-
lding to exclude the rain from the positive partition count (and
herefore include the rain in the negative partitions). In most cases,
areful analysis of known negative samples should be used to help
uide decisions related to the rain. Only in very rare cases does it
ake sense to exclude rain completely from analysis; it should be
lassiﬁed as either the positive or negative partitions.Evaluate partition speciﬁc competition and speciﬁcity
Evaluate SNV sensitivity and performance at low concentration (linearity)
Evaluate probe cross-hybridisation & ﬁlter bleed-through
4.5. Suggested experimental setup to assess dPCR assays
In order to identify the effects from experimental factors that can
inﬂuence the clustering of an assay, we have developed a suggested
experimental set up to assist with assay optimisation (Table 2).
By measuring performance on control samples at particular target
occupancies in duplex and singleplex reactions and comparing the
2D scatter plots a researcher can identify speciﬁcity and PSC effects.
Control samples containing either only WT or variant molecules
can be evaluated in both duplex and uniplex reactions. The sug-
gested concentration for these control samples is to achieve a  of
approximately 0.7 as at this concentration approximately half the
partitions are positive and half are negative for each target.
In the 2D plot, ﬁlter bleed-through is identiﬁed in the uni-
plex reactions as a ‘leaning’ or ‘lifting’ of the corresponding
single-positive cluster. In the absence (or minimal effect) of ﬁlter
bleed-through, probe cross-hybridisation would be identiﬁed by
the ‘lifting’ and ‘leaning’ of the single-positive clusters in the duplex
reactions (Fig. 3A). A similar set up can be designed for higher order
multiplexing experiments with controls for each target.
As it is the presence of both target molecules within a parti-
tion that causes the PSC, analysis with duplex reactions of a sample
containing a 50:50 mix  of the WT  and mutant molecules, with
an expected  value of 0.7 for each molecule would give roughly
equal numbers of partitions in each of the four clusters (Table 2 and
Fig. 3B). Comparison of this 50:50 mix  with WT-only and variant-
only control samples should demonstrate a similar concentration
of each molecule (Table 2).
Sample concentration can also impact on the PSC; as the sam-
ple concentration increases, the likelihood of multiple copies of
each molecule being randomly distributed into each partition also
increases. This will increase the cross-hybridisation and PSC effects
in the single-positive and double-positive partitions, respectively.
Diluting the sample so that there is a smaller proportion of parti-
tions in the double-positive cluster may  improve the quantiﬁcation
by reducing the PSC effects. For example, a dilution of each of the
three samples described to generate concentrations with approxi-
mate  values of <0.05 for the WT-only and variant-only samples
and a  value of <0.025 for the 50:50 mix  (Table 2). This low con-
centration would ensure that almost all the positive partitions are
located in the single-positive cluster.
5. Conclusions
The transition of digital PCR in the last decade from a niche
technology into the mainstream holds signiﬁcant potential to trans-
form our ability to perform precise and highly accurate quantitative
molecular analyses in a wide range of applications. In many cases
we can now perform molecular counting experiments with mul-
tiple targets. This report has illustrated strategies and pitfalls in
achieving such multiplexing. We  showed how important it is to
correctly classify the partitions and how rich the analysis space
can be. While the industry is focussing on improving the workﬂow,
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umber of partitions and detection channels, dPCR will realize its
ull potential when the analysis of such rich cases is transformed
nto simple and intuitive end-user solutions. Furthermore, develop-
ent of appropriate reference materials for assay optimisation for
uplex and higher order multiplexing reactions that enable con-
dent identiﬁcation of the different partition clusters would be
ugely beneﬁcial.
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